A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis | MicrobiomeTrials← Back to trialsNCT07299019
A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis
RecruitingPHASE3INTERVENTIONAL
Trial Details
Start: 2026-03-23Est. Completion: 2030-06
Enrollment target: 990 participants Locations- Arizona Neuroscience Research, LLC, Phoenix, Arizona, United States
- Perseverance Research Center, LLC (PRC), Scottsdale, Arizona, United States
- Fullerton Neurology and Headache Center, Fullerton, California, United States
- Harbor-UCLA Medical Center - The Lundquist Institute (Los Angeles Biomedical Research Institute (LA BioMed)), Torrance, California, United States
- Regina Berkovich MD, PhD Inc, West Hollywood, California, United States
- SFM Clinical Research, LLC, Boca Raton, Florida, United States
- Nova Clinical Research, LLC, Bradenton, Florida, United States
- MS and Neuromuscular Center of Excellence, Clearwater, Florida, United States
- Neurology Associates, Maitland, Florida, United States
- Aqualane Clinical Research, Naples, Florida, United States
- Josephson Wallack Munshower Neurology, Pc Suite 225, Indianapolis, Indiana, United States
- KC Research Center, PA Neurology Research Dept, Roeland Park, Kansas, United States
- Boston Clinical Trials, Boston, Massachusetts, United States
- Profound Research LLC at Oakland Neurology Center, Rochester Hills, Michigan, United States
Other microbiome trials you might be interested in
B-cell Mediated Autoimmune Disorders
The main objective of the study is to determine the recommended phase 2 dose (RP2D) of Azercabtagene zapreleucel (azer-c…
La Jolla, United StatesEst. completion Dec 1, 2026
Advanced Multiple SclerosisProgressive Multiple Sclerosis
MS is a chronic inflammatory and degenerative disease of the central nervous system (CNS) affecting more than 120,000 pe…
Belfast, United KingdomEst. completion Dec 31, 2027
Washington University School of Medicine, St Louis, Missouri, United StatesThe Boster Center for Multiple Sclerosis, Columbus, Ohio, United StatesOMRF Multiple Sclerosis Center of Excellence, Oklahoma City, Oklahoma, United StatesPremier Neurology, Greenville, South Carolina, United StatesNeurology Clinic, P.C., Cordova, Tennessee, United StatesLone Star Neurology, San Antonio, Texas, United StatesTexas Institute for Neurological Disorders - Sherman, Sherman, Texas, United StatesKlinicki Bolnicki Centar Zagreb-Rebro, Zagreb, CroatiaNEUROHK, s.r.o., Choceň, CzechiaAstra clinic (Clinic4U), Tallinn, Harju, EstoniaIRCCS Istituto Neurologico Mediterraneo Neuromed, Pozzilli, Isernia/Molise, ItalyHospital of Lithuanian University of Health Sciences, Kaunas, Kauno, LithuaniaCentrum Medyczne INTERCOR Sp. z o.o., Bydgoszcz, Kuyavian-Pomeranian Voivodeship, PolandTwoja Przychodnia Centrum Medyczne Nowa Sól, Nowa Sól, Lubusz Voivodeship, PolandNmedis sp. z o.o., Rzeszów, Rzeszów, PolandNZOZ Novo Med, Katowice, Silesian Voivodeship, PolandTwoja Przychodnia PCM, Poznan, Wielkopolska, PolandNzoz Neuro-Kard Ilkowski I Partnerzy Spolka Partnerska Lekarzy, Poznan, Wielkopolska, PolandMA-LEK Clinical Sp. z o.o., Katowice, PolandGalen Clinic, Lublin, PolandMalva Trials, Lublin, PolandEUROMEDIS Osrodek Badan Klinicznych, Szczecin, PolandPRO SALUS Sp. z o.o. sp.k., Lodz, Łódź Voivodeship, PolandCaribbean Center for Clinical Research, Guaynabo, Puerto RicoUniversity Clinical Centre of Kragujevac, Kragujevac, Serbia